Free-to-play 3v3 shooter Spectre Divide is being shut down six months after its initial launch in September 2024, and just weeks after its arrival on PS5 and Xbox Series X|S. Its developer ...

Before Star Trek became so popular, Gene Roddenberry, the creator of the show, faced several challenges just to launch it back in the 1960s.

Back in the 1960s, when TV was still playing it safe and very white, Star Trek creator Gene Roddenberry didn’t back down from a fight. When network executives pushed for an all-white cast, Roddenberry ...

In a study by researchers at the University of Bayreuth, common house spiders (Parasteatoda tepidariorum) had a gene inserted for a red fluorescent protein in addition to having an existing gene ...

Star Trek creator Gene Roddenberry was known for implementing specific ideas to keep up with his vision for the illustrious franchise.

Doctors announced this week that they have treated a newborn baby with a rare genetic disease using the world’s first personalized gene editing therapy. Geoff Bennett discussed the treatment and ...

The newest addition, Chris Truby, who was the manager of the Pirates' AAA team in Indianapolis, and then there's *** return to the bench of Gene Lamont. He was the Pirate manager from 1997 to 2000.

That said, it’s important to stay a bit clear-eyed about the way things are, too. Like Gene Roddenberry, Bienvenu is imagining a hopeful far-future, and a pretty miserable near-future that’s a ...

News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy. The treatment corrects ...

As the first series in the franchise specifically aimed at younger audiences, Star Trek: Prodigy successfully introduced the core tenets of Starfleet and the optimistic vision of Gene Roddenberry ...

An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly disease, doctors reported Thursday—a breakthrough in the futuristic ...

The treatment, described in a new study published in The New England Journal of Medicine and presented at the American Society of Gene and Cell Therapy meeting, relies on a complex therapy known ...